Towards selective mycobacterial ClpP1P2 inhibitors with reduced activity against the human proteasome

by Moreira, W, Santhanakrishnan, S, Ngan, G.J.Y, Low, C.B, Sangthongpitag, K, Poulsen, A, Dymock, B.W, Dick, T
Published 2020

Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR

by Kang, C., Gayen, S., Wang, W., Severin, R., Chen, A.S., Lim, H.A., Chia, C.S.B., Schüller, A., Doan, D.N.P., Poulsen, A., Hill, J., Vasudevan, S.G., Keller, T.H.
Published 2014

Identification of covalent active site inhibitors of dengue virus protease

by Koh-Stenta X., Joy J., Wang S.F., Kwek P.Z., Wee J.L.K., Wan K.F., Gayen S., Chen A.S., Kang C., Lee M.A., Poulsen A., Vasudevan S.G, Hill J., Nacro K.
Published 2018

Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria

by Moreira W., Ngan G.J.Y., Low J.L., Poulsen A., Chia B.C.S., Ang M.J.Y., Yap A., Fulwood J., Lakshmanan U., Lim J., Khoo A.Y.T., Flotow H., Hill J., Raju R.M., Rubin E.J., Dick T.
Published 2018